Human Genetics

, Volume 84, Issue 6, pp 582–583 | Cite as

Reply to letter by M. Poot and H. Hoehn

  • Berardino Porfirio
  • Bruno Dallapiccola
Letter to the Editors


Internal Medicine Metabolic Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Barosi G, Cazzola M, Marchi A, Morandi S, Perani V, Stefanelli M, Perugini S (1978) Iron kinetics and erythropoiesis in Fanconi's anemia. Scand J Haematol 21:29–39Google Scholar
  2. Borg DC, Schaich KM (1986) Prooxidant action of desferrioxamine: Fenton-like production of hydroxyl radicals by reduced ferrioxamine. J Free Radic Biol Med 2:237–243Google Scholar
  3. Boyland E, Williams K (1965) An enzyme catalysing the conjugation of epoxides with glutathione. Biochem J 94:190–197Google Scholar
  4. Cerutti PA (1985) Pro-oxidant states and tumor promotion. Science 227:375–381Google Scholar
  5. Davies MJ, Donkor R, Dunster CA, Gee CA, Jonas S, Willson RL (1987) Desferrioxamine (desferal) and superoxide free radicals. Formation of an enzyme-damaging nitroxide. Biochem J 246:725–729Google Scholar
  6. De Meester C (1984) Increase of 2,3-epoxybutane mutagenicity by glutathione-S-transferases. Toxicol Lett 21:255–262Google Scholar
  7. Halliwell B (1985) Use of desferrioxamine as a “probe” for iron-dependent formation of hydroxyl radicals. Biochem Pharmacol 34:229–233Google Scholar
  8. Hochstein P, Atallah AS (1988) The nature of oxidants and antioxidant systems in the inhibition of mutation and cancer. Mutat Res 202:363–375Google Scholar
  9. Kang DS, Harvey SC, Wells RD (1985) Diepoxybutane forms a monoadduct Z-form (dG-dC)n · (dG-dC)n and crosslinked diadduct with the left-handed Z-form. Nucleic Acids Res 13:5645–5656Google Scholar
  10. Lederman HM, Cohen A, Lee JWW, Freedman MH, Gelfand EW (1984) Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood 64:748–753Google Scholar
  11. Lown JW (1983) The mechanism of action of quinone antibiotics. Mol Cell Biochem 55:17–40Google Scholar
  12. Meister A (1983) Selective modification of glutathione metabolism. Science 220:472–477Google Scholar
  13. Morehouse KM, Flitter WD, Mason RP (1987) The enzymatic oxidation of desferal to a nitroxide free radical. FEBS Lett 222:246–250Google Scholar
  14. Nocka KH, Pelus LM (1988) Cell cycle specific effects of deferoxamine on human and murine hematopoietic progenitor cells. Cancer Res 48:3571–3575Google Scholar
  15. Parker RE, Isaacs NS (1959) Mechanisms of epoxide reactions. Chem Rev 59:737–799Google Scholar
  16. Poot M, Rabinovitch PS, Hoehn H (1989) Free radical mediated cytotoxicity of desferrioxamine. Free Radic Res Commun 6:323–328Google Scholar
  17. Porfirio B, Ambroso G, Giannella G, Isacchi G, Dallapiccola B (1989) Partial correction of chromosome instability in Fanconi anemia by desferrioxamine. Hum Genet 83:49–51Google Scholar
  18. Simic MG (1988) Mechanisms of inhibition of free-radical processes in mutagenesis and cancerogenesis. Mutat Res 202:377–386Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • Berardino Porfirio
    • 1
  • Bruno Dallapiccola
    • 1
  1. 1.Department of Public Health and Cell Biology2nd University of RomeRomeItaly

Personalised recommendations